[ET Net News Agency, 13 November 2025] 3SBIO (01530) rose 10% to HK$33.74.
It hits an intra-day high of HK$33.74, hitting an 1-month high, and an intra-day low of HK$31. The total shares traded was 48.48 million, with a value of HK$1.58b. The active buy/sell ratio is 64:36, with net buying turnover of HK$431.89m. CHINA INNOVATION MARKET SER accounts for greatest net responsive buying turnover of HK$32.17m, with volume weighted average price of HK$32.686. CHINA INV INFO accounts for greatest net responsive selling turnover of HK$149.88m, with volume weighted average price of HK$32.675. The stock has risen a combined 17.1% over the past 4 consecutive trading days.
Basic Information| Nominal | 33.740 | % Chg | +10.05% |
| High | 33.740 | Low | 31.000 |
| Shares Tr | 48.48m | Turnover | 1.58b |
| 10-D SMA | 30.498 | %H.V | 64.828 |
| 20-D SMA | 29.316 | VWAP | 32.610 |
| 50-D SMA | 30.246 | RSI14 | 63.867 |
Status: Hitting an 1-month high, active buy/sell ratio is 64:36, with net buying turnover of HK$431.89m, rising a combined 17.1% over the past 4 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| 3SBIO (01530) | 33.74 | +10.05 |
| SINO BIOPHARM (01177) | 7.41 | +7.08 |
| HENGRUI PHARMA (01276) | 72.95 | +1.60 |
| EVEREST MED (01952) | 46.70 | +0.30 |
| WUXI XDC (02268) | 70.85 | +4.96 |
| SKB BIO-B (06990) | 453.00 | +4.72 |
| DUALITYBIO-B (09606) | 334.40 | +8.92 |
| ZAI LAB (09688) | 17.13 | -0.70 |
| AKESO (09926) | 121.60 | +3.31 |
| REMEGEN (09995) | 84.80 | +5.21 |
(ed)
